Guardant Health, Inc.

Patents = 122

Trademarks = 15

Forward Citations = 1,416

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

61 inventors (with patents filed for the assignee):

Guardant Health, Inc. is a leading precision oncology company focused on helping conquer cancer globally through non-invasive cancer screening tests, genomic analysis, and advanced diagnostics. The company's flagship product, Guardant360, is a comprehensive liquid biopsy test that enables advanced cancer detection and monitoring.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com